References
1. Mekonnen A, Redley B, Manias E. Medication-related harm in older
adults: underdiagnosed. MJA Insight+ Issue 22/13 June 2022.
2. Lim R, Ellett LMK, Semple S, et al. The extent of medication-related
hospital admissions in Australia: A review from 1988 to 2021. Drug
Saf. 2022;45(3):249-257.
3. Page AT, Falster MO, Litchfield M, et al. Polypharmacy among older
Australians, 2006-2017: a population-based study. Med J Aust.2019;211(2):71-75.
4. Pardo-Cabello AJ, Manzano-Gamero V, Zamora-Pasadas M, et al.
Potentially inappropriate prescribing according to STOPP-2 criteria
among patients discharged from Internal Medicine: prevalence, involved
drugs and economic cost. Arch Gerontol Geriatr. 2018;74:150-154.
5. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in
elderly people: how well can it be measured and optimised? Lancet
(London, England). 2007;370(9582):173-184.
6. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for
potentially inappropriate prescribing in older people: version 2.Age Ageing. 2014;44(2):213-218.
7. Mekonnen AB, Redley B, de Courten B, et al. Potentially inappropriate
prescribing and its associations with health-related and system-related
outcomes in hospitalised older adults: A systematic review and
meta-analysis. Br J Clin Pharmacol. 2021;87(11):4150-4172.
8. Manias E, Kabir MZ, Maier AB. Inappropriate medications and physical
function: a systematic review. Ther Adv Drug Saf.
2021;12:20420986211030371.
9. Kaufmann CP, Tremp R, Hersberger KE, et al. Inappropriate
prescribing: a systematic overview of published assessment tools.Eur J Clin Pharmacol. 2014;70(1):1-11.
10. Eshetie TC, Roberts G, Nguyen TA, et al. Potentially inappropriate
medication use and related hospital admissions in aged care residents:
the impact of dementia. Br J Clin Pharmacol. 2020
;86(12):2414-2423.
11. Manias E, Kusljic S, Lam DL. Use of the Screening Tool of Older
Persons’ Prescriptions ( STOPP) and the Screening Tool to Alert doctors
to the Right Treatment ( START) in hospitalised older people.Australas J Ageing. 2015;34(4):252-258.
12. Manias E, Maier A, Krishnamurthy G. Inappropriate medication use in
hospitalised oldest old patients across transitions of care. Aging
Clin Exp Res. 2019;31(11):1661-1673.
13. Ní Chróinín D, Neto HM, Xiao D, et al. Potentially inappropriate
medications ( PIMs) in older hospital in-patients: Prevalence,
contribution to hospital admission and documentation of rationale for
continuation. Australa J Ageing. 2016;35(4):262-265.
14. Poudel A, Peel NM, Nissen L, et al. Potentially inappropriate
prescribing in older patients discharged from acute care hospitals to
residential aged care facilities. Ann Pharmacother .
2014;48(11):1425-1433.
15. van der Stelt CAK, Vermeulen Windsant-van den Tweel AMA, Egberts
ACG, et al. The Association between potentially inappropriate
prescribing and medication-related hospital admissions in older
patients: A nested case control study. Drug Saf.2016;39(1):79-87.
16. Counter D, Millar JW, McLay JS. Hospital readmissions, mortality and
potentially inappropriate prescribing: a retrospective study of older
adults discharged from hospital. Br J Clin Pharmacol.2018;84(8):1757-1763.
17. Bo M, Quaranta V, Fonte G, et al. Prevalence, predictors and
clinical impact of potentially inappropriate prescriptions in
hospital-discharged older patients: A prospective study. Geriatr
Gerontol Int. 2018;18(4):561-568.
18. De Vincentis A, Gallo P, Finamore P, et al. Potentially
inappropriate medications, drug–drug interactions, and anticholinergic
burden in elderly hospitalized patients: does an association exist with
post-discharge health outcomes? Drugs Aging. 2020;37(8):585-593.
19. Fabbietti P, Ruggiero C, Sganga F, et al. Effects of
hyperpolypharmacy and potentially inappropriate medications (PIMs) on
functional decline in older patients discharged from acute care
hospitals. Arch Gerontol Geriatr. 2018;77:158-162.
20. Bachmann M, Kool J, Oesch P, Weber M, Bachmann S. Association of
potentially inappropriate medications with outcomes of inpatient
geriatric rehabilitation : A prospective cohort study. Zeitschrift
fur Gerontologie und Geriatrie. 2018;51(7):813-820.
21. Chan CH, Maddison C, Reijnierse EM, Lim WK, Maier AB. The
association of comorbidity measures and mortality in geriatric
rehabilitation inpatients by cancer status: RESORT. Support Care
Cancer. 2021;29(8):4513-4519.
22. Ramsey KA, Rojer AGM, van Garderen E, et al. The association of
changes in physical performance during geriatric inpatient
rehabilitation with short-term hospital readmission,
institutionalization, and mortality: RESORT. J Am Med Dir Assoc.2022 ;23(11):1883.e1-1883.e8.
23. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a
combined comorbidity index. J Clin Epidemiol.1994;47(11):1245-1251.
24. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical
illness burden in geropsychiatric practice and research: application of
the Cumulative Illness Rating Scale. Psychiatry Res.1992;41(3):237-248.
25. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of
fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495.
26. Folstein MF, Folstein SE, McHugh PR. ”Mini-mental state”. A
practical method for grading the cognitive state of patients for the
clinician. J Psychiatr Res. 1975;12(3):189-198.
27. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal
Cognitive Assessment, MoCA: a brief screening tool for mild cognitive
impairment. J Am Geriatr
Soc. 2005;53(4):695-699.
28. Storey JE, Rowland JT, Basic D, et al. The Rowland Universal
Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment
scale. Int Psychogeriatr. 2004;16(1):13-31.
29. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the
aged. The index of ADL: a standardized measure of biological and
psychosocial function. JAMA. 1963;185:914-919.
30. Lawton MP, Brody EM. Assessment of older people: self-maintaining
and instrumental activities of daily living. Gerontologist.1969;9(3):179-186.
31. Komagamine J, Yabuki T, Kobayashi M. Association between potentially
inappropriate medications at discharge and unplanned readmissions among
hospitalised elderly patients at a single centre in Japan: a prospective
observational study. BMJ Open. 2019;9(11):e032574.
32. Chang WT, Kowalski SR, Sorich W, et al. Medication regimen
complexity and prevalence of potentially inappropriate medicines in
older patients after hospitalisation. Int J Clin Pharm.2017;39(4):867-873.
33. Gutiérrez-Valencia M, Alonso-Renedo J, González-Glaría B, et al.
Impact of hospitalization in an acute geriatric unit on polypharmacy and
potentially inappropriate prescriptions: A retrospective study.Geriatr Gerontol Int. 2017;17(12):2354-2360.
34. Mekonnen A, Redley B, Crawford K, et al. Associations between
hyper-polypharmacy and potentially inappropriate prescribing with
clinical and functional outcomes in older adults. Expert Opin Drug
Saf. 2022;21(7):985-994.
35. Basnet S, Zhang M, Lesser M, et al. Thirty-day hospital readmission
rate amongst older adults correlates with an increased number of
medications, but not with Beers medications. Geriatr Gerontol
Int. 2018;18(10):1513-1518.
36. Fabbietti P, Di Stefano G, Moresi R, et al. Impact of potentially
inappropriate medications and polypharmacy on 3-month readmission among
older patients discharged from acute care hospital: a prospective study.Aging Clin Exp Res. 2018;30(8):977-984.
37. Weir DL, Lee TC, McDonald EG, et al. Both new and chronic
potentially inappropriate medications continued at hospital discharge
are associated with increased risk of adverse events. J Am Geriatr
Soc. 2020 Jun;68(6):1184-1192.
38. Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and
enablers to minimising potentially inappropriate medications in adults:
a systematic review and thematic synthesis. BMJ Open.
2014;4(12):e006544.
39. Tobiano G, Chaboyer W, Teasdale T, et al. Older patient and family
discharge medication communication: A mixed-methods study. J Eval
Clin Pract. 2021;27(4):898-906.